JPRN-C000000146已完成3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207) - Cisplatin-containing combination vs single-agent chemotherapy in elderly patients with adavanced non-small-cell lung cancer (JCOG0207 Elderly NSCLC/D vs DP)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 230 人开始时间: 2005年9月9日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 230
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Symptomatic brain metastasis 2) Active another neoplams 3) Severe SVC syndrome 4) Massive pericardial, pleural effusion, or ascites 5) Bone metastasis emergent for palliative radiotherapy or surgery 6) Uncontrollable systemic hypertension 7) Heart failure, Unstable angina Myocardial infarction within 6 months 8) Uncontrollable diabetes 9) Active infection 10) Interstitial pneumonia/ Pulmonary fibrosis 11) Hypersensitivity for polysolbate 80 12) Systemic administartion of corticosteroids
研究者
相似试验
已完成
3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)non-small-cell lung cancerJPRN-UMIN000001424Japan Clinical Oncology Group(JCOG)380
已完成
1 期
Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)JPRN-UMIN000001737Japan Clinical Oncology Group (JCOG)64
已完成
3 期
Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)on-small cell Lung CancerJPRN-C000000027Japan Clinical Oncology Group(JCOG)284
招募中
2 期
The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate CancerHormone Sensitive Metastatic Prostate CancerDNA Damage Repair DeficiencyChemotherapy EffectChemotherapeutic ToxicityNCT05461261The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School50
已完成
3 期
Randomised phase III study of docetaxel versus active symptom control in patients with relapsed gastric adenocarcinomaCancerGastric cancerISRCTN13366390Cambridge University Hospitals NHS Foundation Trust (UK)180